Pharmacology Flashcards
6-mercaptopurine (6-MP)
6-thioguanine (6-TG)
Azathioprine (prodrug of 6-MP)
purine analogs
inhibit de novo purine synthesis
pathway 1:: activated by hypoxanthineguanine phosphoribosyl transferase (HGPRT) to make active metabolites resulting in purine synthesis inhibition (cytotoxic)
pathway 2: Allopurinol competitively inhibits Xanthine oxidase(XO) and thiopurine methyltransferase (TPMT) in the liver and preventing formation of inactive metabolites. Results in shunting to pathway 1 and increased activation
use: IBD and maintenance of cancer remission, organ rejection, RA, SLE, steroid weaning off
Mycophenolate and ribavirin
inhibits inosine monophosphate dehydrogenase
IMP –x—> GMP
Hydroxyurea
Inhibits ribonucleotide reductase in purine and pyrimidine synthesis in s phase
for myeloproliferative disorders and sickle cell (increased levels of HbF)
Methotrexate (MTX), trimethoprim (TMP), Pyrimethamine
inhibits dihydrofolate reductase (decrease dTMP)
humans (methotrexate)
bacteria (trimethoprim)
protozoa(pyrimethamine)
5-fluorouracil (5-FU)
prodrug: capecitabine
forms 5-F-dUMP which inhibits thymidylate synthase (decrease dTMP) and decreases DNA synthesis
cancer drug
AR:handfoot syndrome (palmarplantar erythrodysesthesia)
allopurinol and febuxostat
Treatment for Lesch-Nyhan syndrome (HGPRT)
allopurinol which prevents hypoxanthine from becoming xanthine –> chronic gout tx
Or
febuxostat which prevents xanthine from becoming uric acid —> chronic gout tx
Actinomycin D
inhibits RNA polymerase in both prokaryotes and eukaryotes
Rifampin
inhibits DNA dependent RNA pol in prokaryotes
Quabain
cardiac glycoside that inhibits Na-K ATPase by binding to K site
digoxin and digitoxin
cardiac glycosides
inhibit the Na-K ATPase and indirect inhibition of Na/Ca exchange
increase in Ca concentrations
increased contractility
lumacaftor and ivacaftor
lumacaftor - corrects misfolded proteins and transport to cell surface
ivacaftor- opens Cl- channels
for CF
Fomepizole
FOMEpizole
inhibits alcohol dehydrogenase
For Overdose of Methanol or Ethylene Glycol
Disulfiram
DIScourage drinking by causing hangover
inhibits acetaldehyde dehydrogenase
acetaldehyde accumulates
Electron transport inhibitors
Directly inhibit electron transport
RotenONE inhibits complex I
Antimycin A inhibits complex III (an-THREE-mycin)
CyanIDE, carbon monoxIDE, axIDE (the “ides” –> 4 letters –> complex IV)
ATP synthase inhibitors
oligomycin
increases proton gradient and no ATP produced
Cyclosporine
immunosuppressant (Calcineurin inhibitor)
binds cyclophilin and blocks IL-2 transcription –> no T cell activation
use: prevent transplant rejection and inflammatory disorders
AR: metabolized by CYP 3A4 therefore avoid grapejuice, Highly NEPHROTOXIC, gingical hyperplasia, hirsutism
Tacrolimus
immunosuppressant (calcineurin inhibitor)
binds FK506 binding protein
Blocking T cell activation by preventing IL-2 transcription
use: prevent transplant rejection and inflammatory disorders
AR: NEPHROTOXIC and increased risk of diabetes
Sirolimus (Rapamycin)
Immunosuppressant and for kidney transplant rejection prophylaxis “kidney sir-vives”
AR: pancytopenia, not nephrotoxic
Basiliximab
immunosuppresant and for kidney transplant rejection prophylaxis
Blocks IL-2R
AR: edema, tremor, HTN
Azathioprine
Immunosuppresant
blocks lymphocyte proliferation by blocking nucleotide synthesis. “azathioPURINE”
degraded by xanthine oxidase
AR: panyctopenia
Mycophenolate
Mofetil
immunisuppresant
For lupus nephritis
inhibits IMP dehydrogenase –> preventing purine synthesis
Less nephrotoxic and neurotoxic
AR: pancytopenia, HTN, hyperglycemia
Glucocorticoids
immunosuppressant
Inhibits NFkB.
Decreasing transcription of many cytokines and induces T cell apoptosis
AR: cushings, osteoporosis, hyperglycemia, amenorrhea, peptic ulcers, psychosis, cataracts, avascular necrosis (femoral head).
Used to treat inflammation in graves opthalmopathy
Adrenal insufficiency may develop if drug is stopped abruptly after chronic use –> hypotension and shock
Epoetin alfa (EPO analog)
Bome marrow stimulation
Erythropoietin
used for anemia
especially in renal failure
can cause an increased risk of thromboembolic events and hypertension
Filgrastim (G-CSF)
Sargramostim (GM-CSF)
Bone marrow stimulation
Used for leukopenia
Romiplostim
Eltrombopag
Bone marrow stimulation
Romiplostim is a TPO analog
Eltrombopag is a TPO receptor agonist “Pag=bag for TPO”
Used for autoimmune thrombocytopenia
Aldesleukoin
Immunotherapy of IL2
increases activity of T cells and NKC
used for renal cell carcinoma and metastatic melanoma
IFN-α
immunotherapy of interferon
Used for chronic hep B and renal cell carcinoma
IFN-β
immunotherapy of interferon
used for multiple sclerosis
IFNγ
immunotherapy of interferon
used for chronic granulomatous disease
Alemtuzumab
Therapeutic antibodies
Targets CD52
Used for CLL (chronic lymphocytic leukemia) and MS
think: aLYMtuzumab
Bevacizumab
Therapeutic antibodies
Targets VEGF to inhibit angiogenesis
Used for colorectal cancer, renal cell carcinoma, non small cell lung cancer, treatment for wet age related macular degeneration
Cetuximab
Therapeutic antibodes
Targets EGFR –> decrease KRAS–> decreased cellular growth
Used for stafe 4 colorectal cancer and head/neck cancer
resistance due to mutation in KRAS that activates it
Rituximab
Therapeutic antibodies
Targets CD20
used for B cell non-hodgkin lymphoma, CLL, RA, ITP, multiple sclerosis
AR: progressive multifocal leukoencephalopathy
Trastuzumab
Therapeutic antibodies
Targets HER2
Breast cancer and gastric cancer
think HER2 –>tras2zumab
Adalimumab
Certolizumab
Golimumab
Infliximab
Autoimmune disease therapy
anti TNF α ( key mediatory in inflammatory process by accelerating neutrophil migration, macrophage phagocytosis, lymphocyte proliferation, cytokine synthesis)
Used for autoimmune disorders like IBD, RA, AS, psoriasis
AR: TB risk and drug induced lupus
Daclizumab
Autoimmune disease therapy
Targets CD25 (part of IL-2 receptor)
Used for relapsing MS
Eculizumab
Autoimmune disease therapy
Targets complement protein C5
Used for paroxysmal nocturnal hemoglobinuria
Natalizumab
targets α4 integrin which is important for WBC adhesion
USed for MS, crohns disease
Risk of PML in patients with JC virus
Ustekinumab
Targets IL12 and IL23
Used for psoriasis and psoriatic arthritis
Abciximab
targets platelet glycoproteins IIb/IIIa
used as an antiplatelet agent
Denosumab
mimics osteoprotegerin and targets RANKL
think DenOSumab affects OSteoclasts in OSteoporosis
Digoxin immune Fab
Targets Digoxin
antidote for digoxin toxicity ( yellow tinting seen on objects. REnally cleared with small therapeutic window
therefore increasing age –> decreased renal function –> increased risk of digoxin toxicity
high K+ is also a sign of digoxin toxicity
Omalizumab
refractory allergic asthma thats not responding to inhaled steroids and long acting beta2agonists
prevents IgE binding for FcERI
Palivizumab
Monoclonal antibody directed against the fusion protein of RSV. prevents infection of the host cell
used as RSV prophylaxis for high risk infants
think PaliVIzumab - VIrus
Penicillin
D-Ala-D-Ala structural analog
binds penicilin binding proteins (covalently binds transpeptidase) and blocks crosslinking of peptidoglycan cell wall
Used: Gram + organisms mostly, syphilis, spirochette
AR:hemolytic anemia and intersitital nephritis
Amoxicillin
Ampicillin
Aminopenicillins (amoxi is greater bioavailability)
MOA: same as penicillin but wider spectrum. Combine with clavulanic acid to pretoect against β-lactamase destruction (“they are AMPed up penicillins)
Used: Same as penicillin but wider spectrum
AR: pseudomembranous colitis, rash, hypersensitivity
Resistance: Penicillinase is a type of β-lactamase
Dicloxacillin
Nafcillin
Oxacillin
Penicillinase-resistant penicillins
MOA: bulky R group that blocks access of β-lactamase to β-lactam ring
Use: S aureus “naf for saph”
AR: hypersensitivity, interstitial nephritis
note: beta lactamase function degrade penicillin and cephalosporins
Piperacillin
Ticarcillin
Antipseudomonal penicillins
β-lactamase inhibitors
CAST
Clavulanic acid
Avibactam
Sulbactam
Tazobactam
Cephalosporins
MOA: β-lactam drugs that inhibit cell wall synthesis by irreversibly binding to penicillin binding proteins (i.e. transpeptidase)
note: same as penicillins
note: resistance forms by inhibiting the binding of ceftriaxone via changing the structure of the penicillin binding proteins
First generation cephalosporins
Cefazolin - prior to surgery to prevent S aureus
Cephalexin
2nd gen cephalosporins
Cefaclor
Cefoxitin
Cefuroxime
Cefotetan
3rd gen cephalosporins
Ceftriaxone
Cefotaxime
Cefpodoxime
Ceftazdime —> pseudomonas
can cross BBB therefore use Ceftriaxone for meningitis, gonorrhea, dissemniated lyme disease
note: add ampicillin when tx infant meningitis because if it is due to listeria then 3rd gen wont cover it due to it being intracellular
Cefepime
4th gen cephalosporins
gram (-) organisms with increased activity against pseudomonas and gram +
Ceftaroline
5th gen cephalosporin
Also covers Listeria, MRSA and enterococcus faecalis
does NOT cover pseudomonas
Doripenem
Imipenem
Meropenem
Ertapenem
Carbapenems - beta lactamase inhibitors
Imipenem is always given with cilastatin (an inhibitor of renal dehydropeptidase I) to decrease inactivation of drug in renal tubules
Meropenem is decreased risk of seizures and is stable to dehydropeptidase I
Use: LAST RESORT
AR: seizures at high plasma levels
Aztreonam
Monobactam
MOA: Binds to penicillin binding protein 3 and prevents cross linking.
Synergistic with animnoglycosides.
Use: if pt allergic to penicillin, in pt with renal insufficiency and cant handle aminoglycosides
Vancomycin
MOA: inhibits cell wall peptidoglycan formation by binding D-Ala-D-Ala
use: Gram + only , serious multidrug resistant organisms (i.e. s epidermidis)
AR: Nephrotoxicity, Ootoxicity, Thrombophlebitis, Diffuse flushing (Red man syndrome), eosinophilia and systemic symptoms (DRESS syndrome)
Gentamicin Neomycin Amikacin Tobramycin Streptomycin
Aminoglycosides
MOA: binding of the 30S subunit. requires O2 therefore ineffective against anaerobes. Also, pseudomonas is resistant by inactivating enzyme by acetylation or increasing efflux systems
Use: severe gram (-) rod infections because cant penetrate the cell wall of gram +. Therefore if want to treat gram + too then use with penicillin or some cell wall inhibitor
Neomycin for bowel surgery
AR: Nephrotoxicity, Neuromuscular blockade, Ototoxicity, teratogen
Tetracycline
Doxycycline
Minocycline
Tetracyclines
MOA: bind to 30S and prevent attachment of aminoacyltRNA
Note: Ca, antacids (Mg), Fe
Use: Doxycycline is fecally eliminated and can be used for pt with renal failure . Accumulates intracellularly –> good for intracellular organisms. For Acne and MRSA
AR: discoloration of teeth due to accumulation in dentin and enamel, inhibition of bone growth in children, photosensitivity, CONTRAINDICATED in pregnancy because crosses placenta
Tigecycline
Glycylcycline
MOA: Binds 30S
use: broad spectrum, multiresistant, and infections that require deep tissue penetration
AR: GI sx
Chloramphenicol
Blocks peptidyltransferase at 50S ribosomal subunit
use: Low cost but toxicity –> used in developing countries
AR: anemia (dose dependent aka reversible), APLASTIC ANEMIA (dose independent aka irreversible), gray baby syndrome (lack liver UDP glucuronosyltransferase), leukopenia, thrombocytopenia
Clindamycin
MOA: blocks 50S
use: anaerobic infections ABOVE the diaphragm in aspiration pneumonia, lung abcsess, and oral infections. Also invasive group A strep
AR: pseudomembranous colitis due to C diff
Linezolid
Oxazolidinones
MOA: binds to 50S subunit
USe: Gram + species including MRSA and VRE
AR: bone marrow suppression causes thrombocytopenia, peripheral neuropathy, SEROTONIN SYNDROME due to MAOI activity when used with SSRI
Azithromycin
Clarithromycin
Erythromycin
Macrolides
MOA: 23S rRNA of the 50S
Use: atypical pneumonias, STIs, gram + cocci, pertussis
AR: GI motility issues, prolonged QT interval, acute cholestatic hepatitis, eosinophilia.
Colistin (polymyxin E), polymyxin B
MOA: cation polypeptides that bind to phospholipids and disrupt cell membrane integrity
Use: salvage therapy for multidrug resistant gram - bacteria
Polymyxin B is part of a triple antibotic ointment
AR: nephrotoxicity, neurotoxicity, resp failure
Sulfamethoxazole (SMX)
Sulfisoxazole
Sulfadiazine
Sulfonamides
Inhibit dihydropteroate synthase in folate synthesis.
AR: tubulointerstitial nephritis, stevens johnson syndrome, kernicterus in infants
Dapsone
Similar to sulfonamides but structurally distint
use: Leprosy and prophylaxis for pneumocystis jirovecii
AR: hemolysis if G6PD deficient, methemoglobinemia
Trimethoprim
Inhibits bacterial dihydrofolate reductase
Used with sulfonamides to cause block of folate synthesis.
AR: Bone marrow effects like megaloblastic anemia, Leukopenia, granulocytopenia –> use folinic acid to avoid these
Ciprofloxacin
Enoxacin
Norfloxacin
Ofloxacin
Respiratory:
gemifloxacin
Levofloxacin
moxifloxacin
Fluoroquinolones
MOA: inhibit topo II (DNA gyrase) and topo IV.
DO NOT take with antacids
AR: contraindicated in pregnant women, nursing mothers, and children <18 yo due to possible damage to cartilage. May cause tendonitis or tendon rupture in people >60 yo and in patients taking prednisone.
Daptomycin
MOA: disrupts cell membranes of gram + cocci by creating transmembrane channels causing intracellular ion leakage leading to cell death
Use: MRSA, bacteremia, endocarditis, VRE
AR: myopathy and rhabdomyolysis
note: cant use for pneumo because inactivated by surfactant
Metronidazole
MOA: forms toxic free radical metabolites that damage DNA
Use: treats anaerobic infections BELOW the diaphragm. Can be used to replace amoxicillin for tx of H pylori if penicillin allergy. Bacterial vaginosis and trichomoniasis. GIARDIA
AR: severe flushing, metallic taste. disulfiram like reaction shrotly after ethanol consumption
Rifampin
Rifabutin
Rifamycins
MOA: Inhibits DNA dependent RNA pol
Use: TB, leprosy (use with dapsone to delay resistnace), meningococcal prophylaxis, chemoprophylaxis if in contact with kids with H influenza type b
AR: hepatotoxicity, red/orange body fluids, rapid resistance if used alone
Resistance: rapid resistance if monotherapy
Isoniazid
MOA: decrease synthesis of mycolic acid
Use: mycobacterium tuberculosis
AR: hepatotoxicity, p450 inhibition, drug induced SLE, anion gap metabolic acidosis, can cause sideroblastic anemia due to B6 synthesis def
NOTE: administer vitamin B6 with it because deficiency can cause peripheral neuropathy and sideroblastic anemia.
Pyrazinamide
prodrug of pyrazinoic acid
Works best at acidic pH
Use for mycobacterium tuberculosis
AR: hyperuricemia, hepatotoxicity
Ethambutol
MOA: decrease carb polymerization of mycobacterium cell wall by blocking arabinosyltransferase
use for mycobacterium tuberculosis
AR: optic neuropathy (red green colorblind). think “eyethambutol”
Streptomycin
MOA: interferes with 30S component of ribsosome
use: mycobacterium tuberculosis (2nd line)
AR: tinnitus, vertigo, ataxia, nephrotoxicity
Prophylaxis for high risk of endocarditis and undergoing surgical or dental procedures
amoxicillin
Prophylaxis for exposure to gonorrhea
Ceftriaxone
also give doxycycline and macrolides (azithromycin and eryhtromycin for chlamydia co infection)
Prophylaxis for history of recurrent UTIs
TMP-SMX
Prophylaxis for exposure to meningococcal infection
ceftriaxone, ciprofloxacin, or rifampin
Prophylaxis for women carrying group B strep
intrapartum penicillin G or ampicillin
Prophylaxis for prevention of gonococcal conjunctivitis in newborn
Erythromycin ointment on eyes
Prophylaxis for prevention of postsurgical infection due to S aureus
Cefazolin
Prophylaxis for strep pharyngitis in child with prior rheumatic fever
Benzathine penicillin G or oral penicillin V
Prophylaxis for exposure to syphilis
Benzathine penicillin G
Prophylaxis for HIV patients <200
TMP-SMX for pneumocystis pneumonia
Prophylaxis for HIV patients <100
TMP-SMX for pneumocystis and toxoplasmosis
Prophylaxis for HIV patient <50
Azithromycin or clarithromycin for mycobacterium avium complex
Amphotericin B
MOA: bind ergosterol
think B=binds to and “ amphoTEARicin “Tears” holes into fungal membrane”
“tears holes into kidney becuase nephrotoxic and allows changes in MG AND K (SIDE EFFECT)”
AR: Fever/chills, NEPHROTOXICITY due to vasoconstriction (supplement with K+ and Mg2+ and hydrate) –> hypokalemia and arythmias
Nystatin
Same as amphotericin B. Topical only because too toxic for systemic use
use: swish and swallow for thrush. topical for diaper rash and vaginal candidiasis
Flucytosine
MOA: inhibits DNA and RNA biosynthesis by conversion to 5-fluorouracil by cytosine deaminase
use: systemic fungal infetions in combination with ampho B (cryptococcal)
AR: bone marrow suppression
Clotrimazole Fluconazole Isavuconazole Itraconazole Ketoconazole Miconazole Voriconazole
Azoles
inhibiting conversion of lanosterol to ergosterol
use: local and serious systemic mycoses.
Fluconazole - cryptococcal meningiis in AIDS patients and candidal infections of all types
AR: testosterone synthesis inhibition (gynecomastia, ESPECIALLY with ketoconazole)
Terbinafine
MOA: inhibits the fungal enzyme squalene epoxidase
use: dermatophytes, especially onychomycosis
AR: GI, headache, hepatotoxicity, taste disturbance
Anidulafungin
Caspofungin
micafungin
Echinocandins
MOA: inhibit cell wall synthesis by inhibiting synthesis of beta glucan (major cellw all component is 1,3-BEta, D-glucan)
Use: invasive aspergillosis, candida
AR: GI upset, flushing (by histamine release)
Griseofulvin
MOA: interferes with microtubule function in keratin
Use: oral treatment of superficial infections. inhibits growth of dermatophytes
Adverse effects: teratogen, carcinogenic, icnrease cytochrom P450 and warfarin metabolism
Pyrimethamine
toxoplasmosis
Suramin
Melarsoprol
trypanosoma brucei
Nifurtimox
T cruzi
Sodium stibogluconate
leishmaniasis
Anti mite therapy used to tx scabies and mites
Permethrin- Inhibits Na channel deactivation –> neuronal membrane depolarization
Malathion- (acetylcholinesterase inhibitor)
Lindane- (blocks GABA channels –> neurotoxicity)
Chloroquine
MOA: blocks detoxification of heme into hemozoin. Heme accumulates and is toxic to plasmodia
P falciparum is resistant ( due to membrane pump that has decreased intracellular concentration of drug)
AR: retinopathy, pruritis especially in dark skinner people
Oseltamivir (tamiflu)
Zanamivir
MOA: sialic acid analog. Inhibit influenza A and B neuraminidase which decreases release of progeny virus (aggregates on host cell surface)
Beginning therapy within 48 hours
Why? normally newly formed virus particles initially remain attached to cells and respiratory tract mucins through hemagglutinin binding of glycoconjugate receptors. Neuraminidase cleaves the terminal sialic acid residues on these receptors and allows the release of attached virions and subsequent spread. Inhibition of neuraminidases prevents this
Acyclovir
Famciclovir
Valacyclovir (prodrug of acyclovir, more bioavailable)
MOA: guanosine analogs. Monophosphorylated by HSV/VSV thymidine kinase and not phosphorylated in uninfected cells –> few adverse effects. Preferentially inhibits viral DNA pol by incorporating into replicating viral DNA chain chain termination
AR: obstructive crystalline nephropathy and acute renal failure if not adequately hydrated
Ganciclovir
Guanosine analog.
5’-monophosphate formed by a CMV viral kinase. first line for CMV colitis
Triphosphate formed by cellular kinases that interferes with human host cell DNA synthesis
Prferentially inhibits viral DNA polymerase
AR: neutropenia. if combined with TMP-SMX will cause bone marrow suppression (TMP SMX inhibits tetrahydrofolic acid production)
Foscarnet
Viral DNA/RNA polymerase inhibitor and HIV reverse transcriptase inhibitor. Binds to pyrophosphate-binding site of enzyme. Does not require any kinase activation
think FOScarnet=pyroFOSphate analog
use: CMV retinitis or colitis when ganciclovir fails or acyclovir resistant HSV
AR: nephrotoxic and electrolyte abnormalities can lead to seizures due to chelation (hypomagnesia and hypocalcium )
Cidofovir
MOA: preferentially inhibits viral DNA polymerase. Does not require phosphorylation by viral kinase
use: CMV retinitis in immunocompromised patients; acyclovir resistant HSV
AR: nephrotoxicity
HAART therapy
Highly active antiretroviral therapy (HAART)
in HIV
3 drug regimen: 2 NRTIs and a integrase inhibitor
resistance in pol gene over time (resistance to protease inhibitors and transcriptase inhibitors)
Abacavir (ABC) Didanosine (ddl) Emtricitabine (FTC) Lamivudine (3TC) Stavudine (d4T) Tenofovir (TDF) Zidovudine (ZDV)
HIV - need to be phosphorylated to be active
nucleoside reverse transcriptase inhibitor which inhibitsvnucleotide binding and terminate the SNA chain (lack 3’OH)
all are nucleosides EXCEPT Tenofovir (think nucleoTide)
AR: bone marrow suppression, peripheral neuropathy, lactic acidosis due to nucleosides, anemia with ZDV, pancreatitis with ddl
ABC contraindicated in HLA B5701 mutation pt because of increase hypersensitivity risk
Delavirdine
Efavirenz
Nevirapine
for HIV
Bind to reverse transcriptase at site different from NRTIs. Does not require phosphorylation
AR: rash and hepatotoxicity are common. Efavirenz causes vivid dreams and other CNS symptoms. Delavirdine and efavirenz are contraindicated in pregnancy
Atazanavir Darunavir Fosamprenavir Indinavir Lopinavir Ritonavir Saquinavir
-navir = protease inhibitros which prevent maturation of new viruses by preventing cleavage of the polypeptide products of HIV mRNA into fxional parts
Ritonavir boost other drug concentrations by inhibiting cytochrome P450
AR: hyperglycemia due to insulin resistance, GI, lipodystrophy (chusing like syndrome and fat redistribution), nephropathy, hematuria, thrombocytopenia (indinavir),
Dolutegravir
Elvitegravir
Raltegravir
-tegravir = integrase inhibitors
Inhibits HIV genome integration into host cell chromosome by reversibly inhibiting HIV integrase
AR: increase in creatine kinase
Enfuvirtide
fusion inhibitor for HIV
binds gp41 and inhibits viral entry
think enFUvirtide inhibits FUsion
note: gp120 exoses underlying glycoprotein gp41 which mediates fusion
Maraviroc
fusion inhibitor for HIV
Binds CCR-5 (chemokine receptor on surface of T cells/monocytes to inhibit interaction with gp 120
think MaravirOC inhibits dOCking
Interferons
Interferons for HIV tx
MOA: glycoproteins normally synthesized by virus infected cells, exhibiting a wide range of antiviral and antitumoral properties
use: chronic HBV, HCV, kaposi sarcoma, hairy cell leukemia, condyloma cuminatum, renal cell carcinoma, malignant melanoma, MS, CGD
Adverse effects: flu like, depression, neutropenia, myopathy
HCV is treated via monotherapy or polytherapy?
polytherapy!
Ledipasvir
TX for HCV
viral phosphoprotein (NS5A) inhibitor
NS5A plays important role in replication
Ribavirin
TX for HCV and RSV
interferes with the duplication of viral genetic material
inhibits synthesis of guanine nucleotides by competitively inhibiting inosine monophosphate dehydrogenase
AR: hemolytic anemia and severe teratogen
Simeprevir
HCV protease (NS3/4A); prevents viral replciation
photosensitiviy reactions
Sofosbuvir
inhibits HCV RNA dependent RNA polymerase (NS5B) acting as a chain terminator
Antibiotics to avoid in pregnancy:
Sulfonamides Aminoglycosides Fluoroquinolones Clarithromycin Tetracyclines Ribavirin Griseofulvin chloramphenicol
Sulfonamides --> kernicterus Aminoglycosides --> ototoxicity Fluoroquinolones --> cartilage damage Clarithromycin --> embryotoxic Tetracyclines --> discolored teeth, inhibition of bone growth Ribavirin- teratogen Griseofulvin-teratogenic chloramphenicol - gray baby syndrome
Sympathetic G protein linked second messengers
alpha1 alpha2 beta1 beta2 beta3
alpha1 (q) –> vasoconstriction, mydriasis/dilation, sphincter mm contaction
alpha2 (i) –> decrease sympathetic (adrenergic) outflow, decrease insulin, lipolysis etc
beta1 (s) –> 1 heart (increased contractility)
beta2(s) –> 2 lungs ( bronchodilation etc)
beta3 (s) –>thermogenesis in skeletal mm and bladder relaxation
“qisss”
Parasympathetic G protein linked second messengers
M1
M2
M3
M1 (q) –> higher cognition and enteric NS
M2 (i) –> decrease HR and contractility
M3 (q) –> increase exocrine, gut peristalsis, bladder cotnraction, bronchoconstriction etc
Dopamine G protein linked second messengers
D1
D2
D1 (s) –> relaxes renal vascular smooth mm
D2 (i) –> modulates NT release in brain
Histamine G protein linked second messengers
H1
H2
H1 (q) –> nasal and bronchial mucus production, pruritis etc.
H2 (s) –> increase gastric acid secretion
Vasopressin G protein linked second messengers
V1
V2
V1 (q) –> increase vascular smooth mm contraction
V2(s) –> aquaporin2
Gq
–> phospholipase C–> eventually protein kinase C –> increases [Ca] –> smooth mm contraction
Gs and Gi
Gs –> + adenylyl cyclase –> ATP becomes cAMP –> protein Kinase A –> increase [Ca] in heart and inhibits myosin light chain kinase (smooth mm)
Gi –> (-) adenylyl cyclase
Amphetamine MOA
They use Noradrenergic nerve endings
1) use NE transporter to enter presynaptic terminal
2) use vesicular monoamine transporter (VMA) to enter neurosecretory vesicles
3) NE displaced from vesicle
4) presynaptic threshold
5) expelled
6) drug effects
Cholinomimetic agents
enhance the PNS
watch for exacerbations of COPD, asthma, and peptic ulcers in susceptible patients
Bethanechol
Direct agonists (cholinomimetic agents)
activates bowel and bladder smooth mm
resistant to AChE
Carbachol
Direct agonists (cholinomimetic agents)
carbon copy of acetylcholine but resistant to AChE
Use for contricting pupil and relieving intraocular pressure in open angle glaucoma
Methacholine
Direct agonists (cholinomimetic agents)
stimulate muscarinic receptors in airway
for dx of asthma (methacholine challenge beacause it constricts the bronchioles and increases mucus productions –> further illicit asthma smyptoms)
good for patients with asthma signs but normal spirometery test
Pilocarpine
Direct agonists (cholinomimetic agents)
potent stimulator of swear, tears, and saliva
Resistant to AChE and crosses BBB
open angle (Contracts ciliary mm of eye) and (Contracts pupillary sphincter) closed angle glaucoma, xerostomia (sjogren syndrome)
Donepezil
Rivastigmine
Galantamine
Indirect agonists (anticholinesterases)
increases ACh
used for alzheimers dz
Endrophonium
Indirect agonists (anticholinesterases) increase ACh
in past it was used to dx myasthenia gravis
Neostigmine
Indirect agonists (anticholinesterases) increase ACh
“neo” think No CNS penetration
used for myasthenia gravis, or NMJ blockade etc
Physostigmine
Indirect agonists (anticholinesterases) increase ACh
think phreely crosses BBB (only one that penetrates CNS and PNS)
antidote for anticholinergic toxicity from atropine overdose
Pyridostigmine
Indirect agonists (anticholinesterases) increase ACh
increases mm strength
think pyRIDostiGMine - gets RID of Myasthenia Gravis
does not penetrate CNS
Cholinesterase inhibitor poisoning
usually due to organophosphates which irreversibly inhibit AChE. Antidote is atropine a competitive inhibitor +pralidoxime which regenerates AChE if given early
atropine does not address the nicotinic effects of (mm weakness, paralysis, fluctuations) therefore must add pralidoxime
Atropine
Homatropine
Tropicamide
Muscarinic agents
eye
mydriasis and cycloplegia
Atropine is a competitive muscarinic receptor antagonist that opposes the effects of acetylcholine resulting in decreased muscle contraction intensity
Benztropine
Trihexyphenidyl
Muscarinic agents
CNS
parkinsons dz and acute dystonia related to antipsychotics
“park my benz”
Glycopyrrolate
Muscarinic agents
GI and resp
preop to reduce airway secretions
Hyoscyamine
Dicyclomine
Muscarinic agents
GI
antispasmodics for IBS
Ipratropium
tiotropium
Muscarinic agents
Resp
COPD, asthma
“I pray to breathe soon”
Oxybutynin
Solifenacin
Tolterodine
Muscarinic agents
GI
reduce bladder spasms and urge urinary incontinence
Scopolamine
Muscarinic agents
CNS
motion sickness
Atropine
Muscarinic antagonist (blocks M2)
increase in HR without affecting BP
used to tx bradycardia by decreasing vagal influence on AV and SA node and for ophthalmic applications
risk of glaucoma due to increased intraocular pressure and angle closure
blocks DUMBBELSS
AR: hot as a hare, Dry as a bone, red as a beet, blind as a bat, mad as a hatter, full as a flask. Can cause acute angle closure glaucoma in elderly due to mydriasis. Urinary retention in men with prostatic hyperplasia
Albuterol
Salmeterol
Terbutaline
Sympathomimetics with B2>B1
Albuterol –> acute asthma or COPD
Salmeterol –> long term asthma or COPD
Terbutaline –> acute bronchospasm in asthma and tocolysis
Dobutamine
Sympathomimetics with B1>B2 and alpha
HF, cardiogenic shock, cardiac stress testing
Dopamine
Sympathomimetic with D1=D2>B>A
unstable bradycardia, HF, shock
Alpha effects at high doses
Beta effects at low doses
Epinephrine
Sympathomimetics
B>A
anaphylaxis, asthma, open angle glaucoma, alpha effects predominate at high doses
AR: limits insulin use by insulin sensitive tissues and stimulates hepatic glycogenolysis and gluconeogenesis (like glucagon)
Isoproterenol
Sympathomimetics
Beta1=Beta2
eval of tachyarrhythmias. worsens ischemia
Midodrine
Sympathomimetics
alpha1
autonomic insufficiency and postural HTN
Mirabegron
Sympathomimetics
Beta3
urinary urge incontinence or overactive bladder
“Mira begs ron” to get out of the bathroom”
Norepinephrine
Sympathomimetics
alpha1>alpha2>Beta1
Hypotension and septic shock
reflex bradycardia
Phenylephrine
Sympathomimetics
alpha1>alpha2
hypotension (vasoconstrictor), ocular procedures because mydriatic, rhinitis (decongestant), ischemic priapism
Amphetamine
indirect Sympathomimetics
indirect general agonist, reuptake inhib, releases stored catecholamines
good for ADHD, narcolepsy, obesity
Cocaine
indirect Sympathomimetics
indirect general agonist, reuptake inhib
vasodilation and local anesthesia
dont give beta blocks with it because can lead to unopposed alpha1 activation which can cause extreme HTN and coronary vasospasm
Ephedrine
indirect Sympathomimetics
indirect general agonist and releases stored catecholamines
for nasal decongestion (pseudoephedrine), urinary incontinence, hypotension
Clonidine
Guanfacine
Sympatholytics (alpha2 agonists)
used for hypertensive emergency, ADHD, Tourette syndrome, opioid withdrawal
AR: CNS depression, bradycardia, hypotension, resp depression, miosis, rebound hypertension with abrupt cessation
alpha-methyldopa
Sympatholytics (alpha2 agonists)
first line for HTN in pregnancy
AR: direct coombs + hemolysis, drug induced lupus
Tizanidine
Sympatholytics (alpha2 agonists)
Relief of spasticity, especially in MS
“TICanadine”
AR: Hypotension, weakness, xerostomia
Phenoxybenzamine
Nonselective alpha blocker
Irreversible. Used for pheochromocytoma (preop) to prevent catecholamine (Hypertensive) crisis
AR: ortho hypotension and reflex tachy
Phentolamine
Nonselective alpha blocker
Used for epinephrine reversal
Reversible. Give to pt on MAO inhibitors who eat tyramine containing foods and for severe cocaine induced HTN
AR: ortho hypotension and reflex tachy
Prazosin
Terazosin
Doxazosin
Tamsulosin
alpha1 selective antagonist “osin”
decreases arteriole and venous resistance and decreases the tone of urinary sphincters.
used for urinary sx of BPH
Prazosin can be used for PTSD
Hypertension except for tamsulosin
AR: ORTHOSTATIC HYPOTENSION and vertigo. “first dose” syncope
Mirtazapine
alpha 2 selective antagonist, potent 5HT2 and 5HT3 receptor antagonist and H1 antagonist
used for depression (atypical antidepressant)
AR: increased serum cholesterol, increased appetite, weight gain, dry mouth
Acebutolol Atenolol Betaxolol Bisoprolol Carvedilol Esmolol Labetalol metoprolol Nadolol Nebivolol pindolol propanolol timolol
Beta blockers
decrease HR and contractility and ultimately O2 consumption
-Timolol - Glaucoma to decrease aq humor production
-Propanolol for symptom control of Hyperthyroidism
used for HTN by decreasing CO and DECREASES RENIN SECRETION
- Metoprolol and esmolol for supraventricular tachycardia by decreasing AV conduction velocity (class II antiarrhythic)
- Nadolol, propranolol, carvedilol for variceal bleeding by decreasing hepative venous pressure gradient and portal HTN
also for hypertrophic cardiomyopathy (decrease HR, increase fill time, relieve obstruction) and for decreasing mortality from MI
AR: erectile dysfunction, brady, AV block, HF, seizures, sleep problems, dyslipidemia (metoprolol), and asthma/COPD exacerbation. HYPOGLYCEMIA because hides signs and symptoms that blood sugar is low (palpitations, tremor)
B1 selective blockers
think 1st half of the alphabet (all the ones that are A to M)
. With the exception of carvedilol and labetalol
acebutolol(partial),atenolol, betaxolol,bisoprolol,esmolol,metoprolol
Nonselective blockers
think 2nd half of the alphabet (N to Z)
B1=B2
nadolol,pindolol (partial), propranolol, timolol
Nonselective alpha and B antagonists
Have a different suffix of “-ilol and alol”
carvedilol
labetalol
This beta blocker combines B1 adrenergic blockade with stimulation of B3 receptors
Nebivolol
increases NO
activates NO synthase in the vasculature and decreases systemic vascular resistance
Drugs to avoid according to the beers criteria
alpha blockers due to increased risk of hypotension
anticholinergics, antidepressants, antihistamine, opiods
Benzodiazepines
NSAIDs
PPIs (increased risk of c diff
Treatment for HTN with DM
ACEi and ARBs are protective against diabetic nephropathy
Treatment for HTN with asthma
ARBs
CA channel blcokers
Thiazide diuretics
selective Beta blockers (avoid nonselective to prevent B2 receptor induced bronchocontriction)
avoid ACEi to prevent confusion between drug or asthma related cough
Treatment for HTN in pregnancy
Hydralazine
Labetalol
Methyldopa
Nifedipine
Amlodipine Clevidipine Nicardipine Nifedipine Nimodipine Diltiazem Verapamil
note: dihydropyridines act on arterial smooth mm and are nifedipine, amlodipine, felodipine
note: nondihydropyridines affect the myocardium and are verapamil and diltiazem
“-dipine”
Block voltage dependent L type calcium channels of cardiac and smooth mm
nimodipine (dihydropyridine that acts on vascular smooth mm) –> subarachnoid hemorrhage by preventing cerebral vasospasm.
All other dihydropyridines are for HTN, angina, raynauds
Verapamil (nondihydropyridines that act on the heart, think V=Ventricles) –> HTN, angina, a fib/flutter
amlodipine and nifedipine best for vascular smooth muscle but cause PERIPHERAL EDEMA
Nicardipine and clevidipine is used fot HRN urgency and emergency
Hydralazine
MOA: increase cGMP –> smooth mm relaxation which vasodilates arterioles > veins.
Afterload reduction
Treatment of hypertensive emergency
Clevidipine fenoldopam labetalol nicardipine nitroprusside
Nitroprusside
short acting
increases cGMP via direct release of NO. Can release and cause cynaide toxicity
Fenoldopam
Dopamin D1 receptor agonist - coronary, peripheral, renal, and splanchnic vasodilation
decrease BP and increase natriuresis
use post op as antihypertensive
Nitroglycerin
Isosorbide dinitrate
Isosorbide mononitrate
Nitrates
vasodilate by increasing NO in vascular smooth mm –> increase in cGMP and smooth mm relaxation
Dilates veins»_space;>arteries and decreases preload
use: angina, acute coronary syndrome, pulmonary edema
AR: reflex tachy that can be prevented with beta blockers, tolerance can develop, severe headaches, cutaneous flushing, hypotension
contraindicated in right ventricular infarction (due to reduced preload and CO), hypertrophic cardiomyopathy (due to increased outflow tract obstruction), and those on PDE inhibitors (synergy causes increase in risk of severe hypotension)
Ranolazine
inhibits the late phase of sodium current thereby reducing diastolic wall tension and oxygen consumption. No effect on HR or contractility
use: angina refractory to other medical therapies
AR: QT prolongation
Milrinone
MOA: selective PDE3 inhibitor.
In cardiomyocytes: Increase cAMP–>increase Ca influx –> increase inotrophy and chronotropy
in vascular smooth mm: Increase cAMP –> inhibition of MLCK activity –> general vasodilation
used for short term in acute decompensated HF
AR: arrhythmias, hypotension
Lovastatin
Pravastatin
HMG-CoA reductase inhibitors that increases HDL but decreases TGs and LDL
MOA: inhibit conversion of HMG-CoA to mevalonate a cholesterol precursor. This results in upregulation of LDL receptors to increase uptake of circulatin LDL
AR: hepatotoxicity and myopathy(serum creatinine kinase 10xnormal limit). If used with erythromycin there is inhibition of CYP 3A4 and will result in acute renal failure
Cholestyramine
Colestipol
Colesevelam
Bile acid resins that prevent intestinal reabsorption of bile acids; liver must use cholesterol to make more. Decreases LDL, increases HDL, increases TG (hypertriglyceridemia)
AR: decreases absorption of drugs and fat soluble vitamins
Ezetimibe
prevents cholesterol absorption at small intestine brush border
Decreases LDL, increases or nothing for HDL, Decreases or nothing for TG
Gemfibrozil
Bezafibrate
Fenofibrate
Fibrates
Decreased hepatic VLDL production and
upregulate LPL –> increase TG clearance
Activates PPAR alpha to induce HDL synthesis
AR: MYOPATHY WHEN USED WITH STATINS, cholesterol gallstones due to inhibition of cholesterol 7alpha-hydroxylase
Niacin (B3)
MOA: inhibits lipolysis (hormone sensitive lipase) in adipose tissue; reduces hepatic VLDL synthesis and TGs
AR: red flushed face, hyperglycemia, hepatotoxic, hyperuricemia(acute flare of gouty arthritis) due to decreased renal excretion of uric acid
Alirocumab
Evolocumab
PCSK9 inhibitors
MOA: inactivation of LDL receptor degradation, increasing amount of LDL removed from bloodstream
AR: myalgias, delirium, dementia, other neurocognitive effects
digoxin
Cardiac glycosides
MOA: direct inhibition of Na/K ATPase (decreased Na efflux)–> indirect inhibition of Na/Ca exchanger (decreased Ca efflux)–> increase Ca concentrations –> positive inotropy. It also stimulates vagus neve –> decrease in HR
Use: Increase contractility in HF, decrease conduction in AV node and also depress SA node for a fib. Can be used for a fib
AR: cholinergics side effects, hyperkalemia (poor prognosis), life threatening cardiac dysrhythmia
note: patients with hypokalemia have higher risk of toxicity because available spots on Na/K ATPase for digoxin to bind ( classic drug interaction between digozin and loop diuretics)
antidote: normalize K+ and give anti-digoxin Fab fragments, Mg
Class I antiarrhythmics
slow or block conduction (esp in depolarized cells)
decrease phase 0 slope
selectively depress tissues that are frequently depolarized
Class IA antiarrhythmics
Quinidine
Procainamide
Disopyramide
Increase AP duration, effective refractory period, QT interval
Used for atrial and ventricular arrhythmias
AR: chinchonism (headache,tinnitus with quinidine), reversible SLE like syndrome with procainamide, HF with disopyramide. Thrombocytopenia and torsades
Lidocaine
Mexiletine
Class IB antiarrhythmics (can include phenytoin)
Decrease AP duration. Prefers depolarized or ischemic tissue, has little effect on normal cardiac tissue
Used for post MI acute V arrhythmias and digitalis induced arrhythmias
AR: CNS stimulation/depression, CV depression
Flecainide
Propafenone
Class IC antiarrhythmics
MOA: prolongs ERP in AV node and accessory bypass tracts ONLY
Use: SVT, a fib, last resort for refractory VT
AR: proarrhythmic, contraindicated post-MI and structural or ischemic heart disease
Metoprolol Propranolol Esmolol (very short acting) Atenolol Timolol Carvedilol
note: b1 is in renal and cardiac but not smooth mmemes
Antiarrhythmics - (class II) - Beta blockers
MOA: decrease SA and AV nodal activity by decreasing cAMP, Ca currents. Decreases slope of phase 4
Use: SVT, Ventricular rate control for a fib and a flutter
AR: impotence, COPD and asthma exacerbation, sedation, may mask signs of hypoglycemia.
Metoprolol can cause dyslipidemia
Propranolol can exacerbate vasospasm in prinzmetal angina
Beta blockers can cause unopposed alpha1 agonism if given alone for pheochromocytoma or cocaine toxicity
Amiodarone
Ibutilide
Dofetilide
Sotalol
Antiarrhythmics - potassium channel blockers (Class III)
MOA: increase AP duration, ERP, QT interval
Use: A fib, a flutter and ventricular tachy (amiodarone and sotalol).
spells AIDS
AR:
- Sotalol: torsades, excessive beta blockade
- Ibutilide: torsades
Verapamil
Diltiazem
Antiarrhythmics - calcium channel blockers (class IV)
MOA: decrease conduction velocity, increase ERP, increase PR interval
use: prevent nodal arrhythmias and rate control in a fib
AR: flushing, PERIPHERAL EDEMA, HF, av block (negative chronotropic effect), sinus node depression, COSTIPATION, worsening Congestive HF in patients wiht reduced LV function due to negative inotropic effect
Adenosine
increase K+ out of cell which hyperpolarizes cell and decreases Ica –> decreases AV node conduction
for SVT/paroxysmal supraventricular tachycardia
very short acting. Theophylline and caffeine are adenosine receptor antagonists
AR: flushing, hypotension, chest pain, sense of impending doom, bronchospasm. CORONARY STEAL
Ivabradine
MOA: selective inhibition of funny sodium channels (If), prolonging slow depolarization (phase 4)
decreases SA node firing; negative chronotropic effect without inotropy. Reduces cardiac O2 requirement
Use: chronic stable angina in pt who cant take beta blockers and for chronic HF with reduced EF
AR: luminous phenomena/visual brightness, HTN, bradycardia
What do you give for torsades and digoxin toxicity
Mg 2+
What is first line drug for DM type 2
metformin
What type of insulin is preferred for DKA, hyperkalemia, stress hyperglycemia
Regular short acting insulin
Rapid acting insulin
1 hr peak
lispro
aspart
glulisine
there is no “LAG”